Tag Archives: rosuvastatin

Statin benefits in primary prevention outweigh risk of diabetes

The benefit of preventing vascular events outweighs the increased risk of new-onset diabetes in patients without cardiovascular disease but with an elevated level of high-sensitivity C-reactive protein (hs-CRP), researchers have found. India is the country with the greatest number of diabetes patients in the world, according to the International Diabetes… 

Read more »
Posted in Cardiovascular, Diabetes, Non-Communicable Disease, Non-Communicable Disease Featured 2, Primary Care | Also tagged , , , , , , , , , | Volume: | 2 Responses

Galectin-3 identifies subset of heart failure patients who can benefit from a statin

Blood levels of the carbohydrate-binding protein galectin-3 identified patients with ischemic heart failure who derived significant clinical benefit from rosuvastatin in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) trial. A substudy of CORONA demonstrated that patients with blood levels of galectin-3 <19.0 ng/mL at the start of the… 

Read more »
Posted in Cardiovascular Disease, Pharmacology, Primary Care | Also tagged , , , , , , , , , | Volume: | Leave a comment

Statin therapy has modest effect in preventing pneumonia

Statin therapy may modestly reduce the risk of pneumonia in healthy adults, researchers have found in a subanalysis of the JUPITER study. Key Point: This study offers support for the continued research of statin therapy in the prevention of infection, including lung infection. The use of statins, the first-line therapy… 

Read more »
Posted in Cardiovascular Disease, Infectious Disease, Pharmacology | Also tagged , , , , , , , | Volume: | Leave a comment